Packages for ophthalmic lenses containing pharmaceutical agents

US10661964B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10661964-B2
Application numberUS-201715468311-A
CountryUS
Kind codeB2
Filing dateMar 24, 2017
Priority dateJul 10, 2006
Publication dateMay 26, 2020
Grant dateMay 26, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A packaging for an ophthalmic lens containing a pharmaceutical agent.

First claim

Opening claim text (preview).

What is claimed is: 1. A package containing an ophthalmic lens in solution comprising: a blister bowl, an ophthalmic lens and a pharmaceutical agent; said blister bowl with said pharmaceutical agent heated to an elevated temperature above room temperature; a cover covering said blister bowl; wherein said blister bowl comprises a material that absorbs less than about 16% of said pharmaceutical agent; and wherein the material of the blister bowl is polyetherimide. 2. The package of claim 1 wherein the cover comprises an adhesive laminate, comprising an inner layer. 3. The package of claim 1 wherein said blister bowl comprises a material that absorbs less than about 10% of said pharmaceutical agent. 4. The package of claim 1 wherein said polyetherimide has a glass transition temperature of greater than about 220° C. 5. The package of claim 1 wherein said blister bowl comprises a material that absorbs between less than about 8% and about 3% of said pharmaceutical agents. 6. The package of claim 1 further comprising that the pharmaceutical agent is ketotifen fumarate or one of its salts. 7. A package containing an ophthalmic lens in solution comprising: a blister bowl, an ophthalmic lens and a pharmaceutical agent; said blister bowl with said pharmaceutical agent heated to an elevated temperature at or above 124 C; a cover covering said blister bowl; wherein said blister bowl comprises a material that absorbs less than about 16% of said pharmaceutical agent; and wherein the material of the blister bowl is polyetherimide. 8. The package of claim 7 wherein the cover comprises an adhesive laminate, comprising an inner layer. 9. The package of claim 7 wherein said blister bowl comprises a material that absorbs less than about 10% of said pharmaceutical agent. 10. The package of claim 7 wherein said polyetherimide has a glass transition temperature of greater than about 220° C. 11. The package of claim 7 wherein said blister bowl comprises a material that absorbs between less than about 8% and about 3% of said pharmaceutical agents. 12. The package of claim 7 further comprising that the pharmaceutical agent is ketotifen fumarate or one of its salts.

Assignees

Inventors

Classifications

  • containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen · CPC title

  • B65D81/22Primary

    in moist conditions or immersed in liquids · CPC title

  • A45C11/005Primary

    Contact lens cases (A45C11/046 takes precedence) · CPC title

  • packaging of contact lenses · CPC title

  • for articles of special shape not otherwise provided for · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10661964B2 cover?
A packaging for an ophthalmic lens containing a pharmaceutical agent.
Who is the assignee on this patent?
Johnson & Johnson Vision Care
What technology area does this patent fall under?
Primary CPC classification B65D81/22. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue May 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).